| Medical and Health Sciences | 2021-2025 | 907 | US 315 | 99.78 |
| Clinical Neurology | Lifetime | 47 | US 19 | 99.84 |
| Cellular and Molecular Neuroscience | Lifetime | 338 | US 187 | 98.78 |
| Speech and Hearing | Lifetime | 188 | US 93 | 98.11 |
| Neuroscience of Neurology | Lifetime | 233 | US 100 | 98.15 |
| Clinical Psychology | Lifetime | 910 | US 553 | 98.59 |
| Physical Therapy, Sports Therapy and Rehabilitation | Lifetime | 381 | US 164 | 95.11 |
| Clinical Neurology | 2021-2025 | 9 | US 4 | 99.68 |
| Cellular and Molecular Neuroscience | 2021-2025 | 134 | US 58 | 90.73 |
| Clinical Psychology | 2021-2025 | 694 | US 268 | 92.65 |
| Cognitive Neuroscience | 2021-2025 | 832 | US 345 | 81.98 |
| Psychiatry and Mental health | 2021-2025 | 645 | US 254 | 79.03 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 25 | US 8 | 99.74 |
| Neuromodulation and Treatments for Neurological Disorders | Lifetime | 32 | US 9 | 99.79 |
| Genetic Neurodegenerative Diseases | Lifetime | 32 | US 10 | 99.65 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 49 | US 18 | 99.77 |
| Obsessive-Compulsive Spectrum Disorders | Lifetime | 72 | US 52 | 99.08 |
| Transcranial Magnetic Stimulation Studies | Lifetime | 99 | US 29 | 98.91 |
| Dysphagia Assessment and Management | Lifetime | 119 | US 64 | 98.34 |
| Neuroscience and Neural Engineering | Lifetime | 418 | US 204 | 98.33 |
| Autism Spectrum Disorder Research | Lifetime | 372 | US 240 | 98.12 |
| Neurological and metabolic disorders | Lifetime | 111 | US 50 | 97.39 |
| Voice and Speech Disorders | Lifetime | 204 | US 121 | 97.52 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 77 | US 30 | 95.91 |
| Neurology and Historical Studies | Lifetime | 116 | US 56 | 94.77 |
| Balance, Gait, and Falls Prevention | Lifetime | 667 | US 226 | 95.61 |
| Restless Legs Syndrome Research | Lifetime | 206 | US 59 | 94.40 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 523 | US 166 | 92.38 |
| Neurological diseases and metabolism | Lifetime | 935 | US 317 | 90.74 |
| History of Medicine Studies | Lifetime | 722 | US 265 | 73.16 |
| History of Medical Practice | Lifetime | 928 | US 533 | 67.45 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 7 | US 2 | 99.72 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 21 | US 7 | 99.50 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 46 | US 9 | 97.36 |
| Obsessive-Compulsive Spectrum Disorders | 2021-2025 | 38 | US 10 | 97.48 |
| Botulinum Toxin and Related Neurological Disorders | 2021-2025 | 108 | US 23 | 95.33 |
| Transcranial Magnetic Stimulation Studies | 2021-2025 | 130 | US 33 | 95.40 |
| Autism Spectrum Disorder Research | 2021-2025 | 290 | US 122 | 94.85 |
| Neuroscience and Neural Engineering | 2021-2025 | 377 | US 81 | 92.87 |
| Neurological and metabolic disorders | 2021-2025 | 326 | US 71 | 63.70 |
| Biotechnology and Related Fields | 2021-2025 | 170 | US 42 | 56.64 |
| Vagus Nerve Stimulation Research | 2021-2025 | 975 | US 324 | 51.02 |
| Nuclear Receptors and Signaling | 2021-2025 | 977 | US 205 | 46.27 |
| Parkinson's Disease and Spinal Disorders | 2021-2025 | 734 | US 143 | 27.76 |
